Intelligent Bio Solutions
INBS
8 hedge funds and large institutions have $1.26M invested in Intelligent Bio Solutions in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
1,074% more capital invested
Capital invested by funds: $108K → $1.26M (+$1.16M)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
1.12% more ownership
Funds ownership: 0.18% → 1.29% (+1.1%)
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.15M |
| 2 |
ACM
Altium Capital Management
New York
|
+$278K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$66.2K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$41.8K |
| 5 |
Goldman Sachs
New York
|
+$23.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$21.6K |
| 2 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$14.6K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.12K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.23K |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$373 |
INBS Hedge Fund Activity: Q1 2025 in Review
8 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q1 2025, worth a combined $1.26M — up 1,074% from $108K a quarter earlier.
Fund positioning in INBS was balanced in Q1 2025: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $1.15M. The largest seller was Two Sigma Securities, exiting entirely with an estimated $21.6K sold.
- 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $1.26M of Intelligent Bio Solutions stock for Q1 2025, up 1,074% quarter-over-quarter.
- 4 funds opened new Intelligent Bio Solutions positions in Q1 2025 and 4 closed out, a net change of 0 holders.
- The largest Intelligent Bio Solutions buyer in Q1 2025 was Alyeska Investment Group, an estimated $1.15M added.
- The largest Intelligent Bio Solutions seller in Q1 2025 was Two Sigma Securities, an estimated $21.6K sold.
Based on aggregated 13F filings for Q1 2025.